Trial Profile
The pharmacokinetics of once daily Kaletra and methadone in a population of HIV positiive drug users.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2012
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Methadone (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 15 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record